Q4 2020 Prestige Consumer Healthcare Inc Earnings Call
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presents the results of two patient surveys. The surveys involved over 400 respondents from f
Pfizer, a former dividend aristocrat, has shown slow growth of key financial metrics over the last decade partly due to problems integrating acquisitions and re
Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
May 15, 2020 (The Expresswire) -- Global “Ovulation Test Market ” analysis 2020 covers the entire supply chain, focusing on supply, demand, trade and prices...
Johnson & Johnson’s stock has outperformed the broader markets as well as some of its peers over the last few weeks. While J&J stock grew 32% since the recent lows of March 23, the S&P 500 gained 26
Prestige Consumer Healthcare Inc. (NYSE:PBH) last week reported its latest annual results, which makes it a good time...
The osteoarthritis therapeutics market size has the potential to grow by USD 2.99 billion during 2020-2024
On the call with me today are Ron Lombardi, our Chairman, President and CEO; and Chris Sacco, our CFO. On today's call, we'll begin with some topical remarks, given the current crisis, review the res
Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.
Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE